<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04540276</url>
  </required_header>
  <id_info>
    <org_study_id>Hyperoxia and MINS</org_study_id>
    <nct_id>NCT04540276</nct_id>
  </id_info>
  <brief_title>Intraoperative Hyperoxia and MINS</brief_title>
  <official_title>Intraoperative Hyperoxia and MINS: A Post Hoc Analysis From the VISION Study Database</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Bispebjerg and Frederiksberg</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Population Health Research Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital Bispebjerg and Frederiksberg</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Oxygen therapy is administered to all patients during general anesthesia to maintain tissue&#xD;
      oxygenation and prevent hypoxia and ischemia. However, liberal use of oxygen may lead to&#xD;
      hyperoxia and some studies suggest that supranormal levels of arterial oxygen saturation may&#xD;
      lead to complications. In this post hoc substudy of the VISION cohort, we plan to assess the&#xD;
      association between perioperative inspired oxygen fraction (FiO2) and myocardial injury after&#xD;
      non-cardiac surgery (MINS).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients will be divided into five groups of median intraoperative FiO2 (quintiles), in which&#xD;
      baseline characteristics and outcomes will be illustrated.&#xD;
&#xD;
      The odds ratio (OR) for the primary and secondary outcomes will be calculated in a logistic&#xD;
      regression analysis with median FiO2 (continuous variable) as independent variable.&#xD;
&#xD;
      Analyses are performed with multiple logistic regression with adjustment for the following&#xD;
      potentially confounding variables:&#xD;
&#xD;
      Age ≥75 years. Male sex. Current atrial fibrillation. History of diabetes. History of&#xD;
      congestive heart failure. History of coronary artery disease. History of recent (i.e., &lt; 6&#xD;
      months) high-risk coronary artery disease. History of stroke. History of peripheral vascular&#xD;
      disease. History of hypertension. Preoperative eGFR (&lt;30 vs. 30-44 vs. 45-59 vs. ≥60&#xD;
      mL/min/1.73m2). Low-risk surgery. Duration of surgery.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">February 4, 2018</start_date>
  <completion_date type="Anticipated">March 1, 2021</completion_date>
  <primary_completion_date type="Actual">October 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Myocardial injury after non-cardiac surgery (MINS)</measure>
    <time_frame>Within 30 days after surgery.</time_frame>
    <description>Number of participants with MINS in the specified oxygen groups. MINS is defined as either ischemic troponin elevation or myocardial infarction after non-cardiac surgery.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>All-cause mortality</measure>
    <time_frame>Within 30 days after surgery</time_frame>
    <description>Number of deaths within 30 days after surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Myocardial infarction</measure>
    <time_frame>Within 30 days after surgery</time_frame>
    <description>Number of participants with myocardial infarction within 30 days after surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MINS</measure>
    <time_frame>Within 30 days after surgery</time_frame>
    <description>Number of participants with MINS not fulfilling the fourth universal definition of myocardial infarction</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rehospitalization for vascular reasons</measure>
    <time_frame>Within 30 days after surgery</time_frame>
    <description>Number of participants rehospitalized for vascular reasons within 30 days after surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pneumonia</measure>
    <time_frame>Within 30 days after surgery</time_frame>
    <description>Number of participants with pneumonia within 30 days after surgery</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Vascular mortality</measure>
    <time_frame>Within 30 days after surgery</time_frame>
    <description>Number of vascular deaths within 30 days after surgery</description>
  </other_outcome>
  <other_outcome>
    <measure>Non-fatal cardiac arrest</measure>
    <time_frame>Within 30 days after surgery</time_frame>
    <description>Number of participants with non-fatal cardiac arrest within 30 days after surgery</description>
  </other_outcome>
  <other_outcome>
    <measure>Cardiac revascularization procedure</measure>
    <time_frame>Within 30 days after surgery</time_frame>
    <description>Number of participants undergoing cardiac revascularization procedure within 30 days after surgery</description>
  </other_outcome>
  <other_outcome>
    <measure>Pulmonary embolism</measure>
    <time_frame>Within 30 days after surgery</time_frame>
    <description>Number of participants with pulmonary embolism within 30 days after surgery</description>
  </other_outcome>
  <other_outcome>
    <measure>New-onset clinically important atrial fibrillation</measure>
    <time_frame>Within 30 days after surgery</time_frame>
    <description>Number of participants with new-onset clinically important atrial fibrillation within 30 days after surgery</description>
  </other_outcome>
  <other_outcome>
    <measure>Peripheral arterial thrombosis</measure>
    <time_frame>Within 30 days after surgery</time_frame>
    <description>Number of participants with peripheral arterial thrombosis within 30 days after surgery</description>
  </other_outcome>
  <other_outcome>
    <measure>Severe sepsis or septic shock</measure>
    <time_frame>Within 30 days after surgery</time_frame>
    <description>Number of participants with severe sepsis or septic shock within 30 days after surgery</description>
  </other_outcome>
  <other_outcome>
    <measure>Surgical wound infection</measure>
    <time_frame>Within 30 days after surgery</time_frame>
    <description>Number of participants with surgical wound infection defined as surgical incision infection or surgical abscess</description>
  </other_outcome>
  <other_outcome>
    <measure>Deep venous thrombosis</measure>
    <time_frame>Within 30 days after surgery</time_frame>
    <description>Number of participants with deep venous thrombosis within 30 days after surgery</description>
  </other_outcome>
  <enrollment type="Anticipated">7700</enrollment>
  <condition>Hyperoxia</condition>
  <condition>Myocardial Infarction</condition>
  <condition>Myocardial Injury</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Inspiratory oxygen fraction</intervention_name>
    <description>Median inspiratory oxygen fraction during general anesthesia</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patients entered in the VISION database, undergoing noncardiac surgery in general&#xD;
        anesthesia.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients entered in the VISION database, aged 18 years or above, undergoing noncardiac&#xD;
             surgery in general anesthesia.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with unobtainable data on perioperative FiO2.&#xD;
&#xD;
          -  Patients with unobtainable data on postoperative troponin.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christian S. Meyhoff, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University hospital Bispebjerg Frederiksberg</affiliation>
  </overall_official>
  <overall_official>
    <last_name>PJ Devereaux, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Population Healt Research Institute</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cleveland Clinic</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Walter C. Mackenzie Health Sciences Centre</name>
      <address>
        <city>Edmonton</city>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Prince of Wales Hospital</name>
      <address>
        <city>Hong Kong</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Foundation CardioInfanil</name>
      <address>
        <city>Bogotá</city>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bispebjerg Hospital</name>
      <address>
        <city>Copenhagen</city>
        <state>NV</state>
        <zip>2400</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Christian Medical College</name>
      <address>
        <city>Ludhiāna</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Malaya Medical Centre</name>
      <address>
        <city>Kuala Lumpur</city>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Inkosi Albert Luthuli Hospital</name>
      <address>
        <city>Durban</city>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>China</country>
    <country>Colombia</country>
    <country>Denmark</country>
    <country>India</country>
    <country>Malaysia</country>
    <country>South Africa</country>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>August 31, 2020</study_first_submitted>
  <study_first_submitted_qc>September 4, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 7, 2020</study_first_posted>
  <last_update_submitted>February 3, 2021</last_update_submitted>
  <last_update_submitted_qc>February 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital Bispebjerg and Frederiksberg</investigator_affiliation>
    <investigator_full_name>Sofie Pedersen</investigator_full_name>
    <investigator_title>MD, PhD-student at Dept. of Anesthesia and Intensive Care</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Hyperoxia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

